Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.…
Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026
Instinct Bio Technical Company Holdings (NASDAQ: BIOT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Household & Personal Products industry, part of the Consumer Defensive sector.
The shares were at 0.1432 USD on 20 November 2026. Its 52-week range is 0.1282 USD to 50.00 USD: the price is 99.7% below the high and 11.7% above the low.
Its market capitalisation is 4.12M USD.
Instinct Bio Technical Company Holdings reports return on equity of 3.2% and an operating margin of 0.0%.
Its Piotroski F-score is 6 out of 9, an average reading of its financial health.
No upcoming events tracked.